Hugel Inc. logo

Hugel Inc. (145020)

Market Closed
10 Aug, 06:30
KRX SM KRX SM
279,500. 00
+6,000
+2.1938%
2.47T Market Cap
- P/E Ratio
- Div Yield
71,938 Volume
- Eps
273,500
Previous Close
Add Transaction
Day Range
261,000 281,500
Year Range
208,500 361,000
Want to track 145020 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

145020 closed today higher at ₩279,500, an increase of 2.1938% from yesterday's close, completing a monthly increase of 4.486% or ₩12,000. Over the past 12 months, 145020 stock gained 19.7002%.
145020 is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -1,172.0733%, based on the last three reports.
Hugel Inc. has completed 3 stock splits, with the recent split occurring on Jan 26, 2021.
The company's stock is traded on one exchange.

145020 Chart

People also search for

Samsung Biologics Co., Ltd.
1,569,000
+0.8355%
Celltrion Inc.
201,000
+0.853%
ALTEOGEN Inc.
348,000
+14.0984%
Sk Biopharmaceuticals Co., Ltd.
88,700
+3.8642%
ABL Bio Inc.
93,600
+8.0831%

Hugel Inc. (145020) FAQ

What is the stock price today?

The current price is ₩279,500.00.

On which exchange is it traded?

Hugel Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 145020.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.47T.

Has Hugel Inc. ever had a stock split?

Hugel Inc. had 3 splits and the recent split was on Jan 26, 2021.

Hugel Inc. Profile

Biotechnology Industry
Healthcare Sector
Ms. Carrie C. Strom CEO
KRX SM Exchange
KR7145020004 ISIN
KR Country
589 Employees
- Last Dividend
26 Dec 2019 Last Split
- IPO Date

Overview

Hugel, Inc., founded in 2001 and based in Chuncheon-si, South Korea, is a global biopharmaceutical company that specializes in the development, manufacture, and distribution of a wide range of products across various medical and cosmetic categories. The company operates both within South Korea and internationally, underlining its commitment to providing innovative healthcare solutions around the world. With a focus on research and development, Hugel, Inc. continuously strives to advance in biotechnology and medical science, aiming to improve the quality of life for patients globally through its high-quality products.

Products and Services

Hugel, Inc. offers a diverse portfolio of products and services across multiple domains including biopharmaceuticals, cosmetics, and medical devices. The company's groundbreaking work particularly in the area of botulinum toxins and hyaluronic acid fillers has positioned Hugel as a notable player in the global aesthetic medicine market. Below is an overview of their key products and services:

  • Botulinum Toxin Products:

    Under brand names such as Botulax, Regenox, Zentox, Reage, Magnion, Hugel Toxin, Juvenlife, Botulim, and Botoshot, Hugel, Inc. offers botulinum toxin products. These products are designed for multiple therapeutic and aesthetic applications such as treatment of essential eyelid convulsion in adults, improvement of glabellar lines, treatment of upper limb spasticity post-stroke, dynamic equinus foot deformity in children with cerebral palsy, and improvement of crow's feet. The botulinum toxin products by Hugel highlight the company's focus on expanding therapeutic indications and enhancing aesthetic outcomes.

  • Hyaluronic Acid Fillers:

    The company's hyaluronic acid fillers are marketed under the Dermalax, Hyalsense, Revigance, and The Chaeum brands. These fillers are used for aesthetic purposes such as correcting wrinkles, volumizing facial features, and improving skin hydration and texture. Their high-quality composition ensures safety and efficacy, providing lasting results in skin rejuvenation and aesthetics.

  • Cosmetics:

    Hugel’s cosmetic line, under the Wellage brand, reflects the company’s commitment to not only medical-grade treatments but also daily skincare. These products leverage cutting-edge biotechnology to provide skincare solutions that aim to improve skin health and appearance, following the same high standards set by their medical devices and therapeutics.

  • Medical Devices:

    In addition to pharmaceuticals and cosmetics, Hugel, Inc. offers a range of medical devices. These include devices designed to support and enhance the application of their core product offerings, as well as other medical and aesthetic procedures. These devices underscore Hugel's comprehensive approach to cater to the medical aesthetics industry.

Contact Information

Address: 61-20, Sinbuk-ro
Phone: 82 3 3255 3882